- 1410.972
- +7.795+0.56%
Tesla Price Target Announced at $230.00/Share by Cantor Fitzgerald
Tesla Price Target Announced at $230.00/Share by Cantor Fitzgerald
Tesla Initiated at Overweight by Cantor Fitzgerald
Tesla Initiated at Overweight by Cantor Fitzgerald
Linde on Pace for Largest Percent Decrease Since June 2020 -- Data Talk
Linde plc (LIN) is currently at $419.62, down $23.00 or 5.2% --Would be lowest close since Feb. 14, 2024, when it closed at $418.40 --On pace for largest percent decrease since June 11, 2020, when i
C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining over 50 points on Thursday.Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) rose sharply during Thursday's session after the company repo
BMO Capital Reiterates Outperform on Pfizer, Raises Price Target to $36
BMO Capital analyst Evan David Seigerman reiterates Pfizer with a Outperform and raises the price target from $33 to $36.
Pfizer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 30.74% BMO Capital $33 → $36 Reiterates Outperform → Outperform 04/18/2024 63.43% Cantor Fitzge
Bank Ratings | J.P. Morgan Chase: AMD's first-quarter performance was steady and data center prospects were strong, maintaining a target price of $180
Glonghui, May 2 | J.P. Morgan Chase published a research report saying that Ultrafine Semiconductor announced its results for the first quarter ended at the end of March this year. Sales, profit margins, and earnings per share have all improved, mainly due to quarterly growth in the data center business and seasonal decline of PC customers that were less than expected. However, the performance of embedded industry solutions and gaming-related businesses was weak during the period, offsetting part of the increase. The company predicts that revenue for the second quarter ending the end of June will increase by 4% to 5.7 billion US dollars on a quarterly basis, in line with market expectations. Management revealed that data center GPU revenue is expected to reach more than 4 billion US dollars this year. According to Motong, along with
Barclays Maintains Overweight on Automatic Data Processing, Raises Price Target to $282
Barclays analyst Ramsey El-Assal maintains Automatic Data Processing (NASDAQ:ADP) with a Overweight and raises the price target from $280 to $282.
Changes in US stocks | Popular tech stocks strengthen, Nvidia (NVDA.US) rises nearly 1%
Popular tech stocks strengthened. As of press release, Nvidia had risen nearly 1%
Automatic Data Processing Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 16.18% Barclays $280 → $282 Maintains Overweight 03/26/2024 -3.18% Evercore ISI Group $227 → $2
Market Clubhouse Morning Memo - May 2nd, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, And META)
Good Morning Traders! In today's Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA. Our proprietary formula, exclusive to Market Clubhouse, dictates thes
Tesla Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 25.69% Cantor Fitzgerald → $230 Initiates Coverage On → Overweight 04/29/2024 -20.76% Evercore
What the Options Market Tells Us About Cisco Systems
Whales with a lot of money to spend have taken a noticeably bullish stance on Cisco Systems.Looking at options history for Cisco Systems (NASDAQ:CSCO) we detected 10 trades.If we consider the specific
Advanced Micro Devices's Options Frenzy: What You Need to Know
Financial giants have made a conspicuous bearish move on Advanced Micro Devices. Our analysis of options history for Advanced Micro Devices (NASDAQ:AMD) revealed 33 unusual trades.Delving into the det
Major Bank Ratings | J.P. Morgan Chase: Pfizer's sales of core products in the first quarter met expectations and maintained a “neutral” rating
Glonghui, May 2 | J.P. Morgan Chase published a research report saying that the sales performance of Paxlovid, Pfizer's core product in the first quarter was in line with expectations, and gross margin exceeded expectations by nearly 80%, compared to the company's full-year guidance of about 70%. Although Pfizer's management has not adjusted its annual product sales and gross margin guidelines, Motong believes investors will not be surprised by Pfizer's continued growth in performance this year or adjusted guidelines. It raised its adjusted earnings per share forecast for this year and next to $2.45 and $2.57. The comparison of the company's guidance for this year is between $2.15 and $2.35. The bank's current 2024 sales
Novo Nordisk's Wegovy Sales More Than Doubled. Why the Stock Is Falling. -- Barrons.com
By Callum Keown Novo Nordisk hiked its full-year guidance Thursday as sales of its weight-loss drug Wegovy more than doubled in the first three months of 2024. The Danish pharmaceutical giant, which
Better AI Stock: Microsoft Vs. AMD
Cyprus Seeks Improvements to Chevron-led Plans for Offshore Gas Field
Accenture To Acquire Brazilian Creative Agency SOKO For Undisclosed Terms
JPMorgan Chase Adjusts Price Target on Automatic Data Processing to $250 From $254
Automatic Data Processing (ADP) has an average hold rating and price target range of $238 to $282, according to analysts polled by Capital IQ. Price: 243.06, Change: -4.28, Percent Change: -1.73